Purchases and Sales Made in Q2 2023 in Ocular Therapeutix, Inc (OCUL)
This table provides information about the institutional ownership of Ocular Therapeutix, Inc (OCUL) during Q2 2023. The information is specifically focused on institutions that hold shares of OCULAR THERAPEUTIX, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-26.2K- 8.54% |
$121K - $200K
|
281K
$2.25M
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-46.3K- 65.03% |
$213K - $354K
|
24.9K
$199K
|
|
|
Aug 14, 2023
Q2 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-100K- 50.0% |
$460K - $764K
|
100K
$801K
|
|
|
Aug 14, 2023
Q2 2023
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-144K- 28.14% |
$664K - $1.1M
|
368K
$2.95M
|
|
|
Jul 31, 2023
Q2 2023
|
Levin Capital Strategies, L.P.
New York, NY |
SELL
|
- |
-175K- 84.35% |
$806K - $1.34M
|
32.5K
$260K
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-187K- 57.86% |
$861K - $1.43M
|
136K
$1.09M
|
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-259K- 92.45% |
$1.19M - $1.98M
|
21.1K
$169K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-277K- 18.12% |
$1.27M - $2.11M
|
1.25M
$10M
|
|
|
Aug 14, 2023
Q2 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-326K- 5.34% |
$1.5M - $2.49M
|
5.78M
$46.3M
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-444K- 40.34% |
$2.04M - $3.39M
|
656K
$5.26M
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-949K- 80.3% |
$4.37M - $7.25M
|
233K
$1.86M
|